Irit Avivi

Tel Aviv Medical Center, Israel

Chairman, Tel Aviv Institute of Hematology and Bone marrow transplantation,  Tel Aviv Medical Center

Member Professor, Sackler School of Medicine, Tel Aviv University

Prof Irit Avivi serves as the Director of Hematology division at Sourasky Tel Aviv Medical Center.

She was trained in adult Hemato-Oncology at Rambam Medical Center and completed a fellowship in lymphoma and myeloma at London University College Hospitals.

Her major research and clinical expertise are in prognostication and treatment of myeloma and lymphoma, including the employment of immune- modulating strategies (e.g:  dendritic cell fusion vaccine, regulatory cell depletion, CART cells etc.) and in managing hematological cancers during pregnancy.

She has over 160 scientific publications, has been frequent invited speaker and has won several awards for her immune- translational research in myeloma and Lymphoma.

She has extensive international collaborations with multiple groups in Europe and USA and is highly involved in many pivotal, phase 1-4 clinical studies including CAR-T CELL Therapy in myeloma and lymphoma.

In addition, she has a wide experience in initiating and conducting investigator initiated studies involving multiple centers, exploring new therapeutic approaches for myeloma and lymphoma and involving biomarker studies.

Broadcast Time Zone is Central European Time (CET)
Approximately one week before the Congress, all registered delegates will receive an invitation with personal link to set their profile and enter the virtual Congress platform.  Your personal link will only be valid until the end of the Congress.  In order to view the Congress lectures and panel discussions, delegates must enter the virtual Congress platform and set their profile before the end of the Congress.